S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
Even at $2,000+ Per Share, These 3 Stocks Are Deals
Will NIO Partake In China's Economic Awakening?
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Tax Software Specialist Vertex In Buy Zone After Base Breakout
How to Choose a Brokerage Account or Online Broker
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
Even at $2,000+ Per Share, These 3 Stocks Are Deals
Will NIO Partake In China's Economic Awakening?
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Tax Software Specialist Vertex In Buy Zone After Base Breakout
How to Choose a Brokerage Account or Online Broker
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
Even at $2,000+ Per Share, These 3 Stocks Are Deals
Will NIO Partake In China's Economic Awakening?
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Tax Software Specialist Vertex In Buy Zone After Base Breakout
How to Choose a Brokerage Account or Online Broker
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
Even at $2,000+ Per Share, These 3 Stocks Are Deals
Will NIO Partake In China's Economic Awakening?
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Tax Software Specialist Vertex In Buy Zone After Base Breakout
How to Choose a Brokerage Account or Online Broker
NASDAQ:SEEL

Seelos Therapeutics (SEEL) Stock Forecast, Price & News

$0.92
0.00 (0.00%)
(As of 06/9/2023 ET)
Compare
Today's Range
$0.87
$0.94
50-Day Range
$0.66
$1.06
52-Week Range
$0.58
$1.52
Volume
512,831 shs
Average Volume
471,492 shs
Market Capitalization
$111.46 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.33

SEEL stock logo

About Seelos Therapeutics (NASDAQ:SEEL) Stock

Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of products that address significant unmet needs in Central Nervous System (CNS) disorders and other rare disorders. The company was founded by Raj Mehra in 1987 and is headquartered in New York, NY.

Receive SEEL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Seelos Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

SEEL Stock News Headlines

The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
Seelos Therapeutics (NASDAQ:SEEL) Price Target Cut to $4.00
Free Stock Analysis Report: Get Buy, Sell, or Hold Recommendation
Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.
Seelos Therapeutics, Inc Q1 Loss decreases, but misses estimates
BTIG Reaffirms Their Buy Rating on Seelos Therapeutics (SEEL)
2030, Psychedelic Drugs Market: Trend & Outlook
BTIG Remains a Buy on Seelos Therapeutics (SEEL)
See More Headlines

SEEL Price History

SEEL Company Calendar

Last Earnings
5/15/2023
Today
6/09/2023
Next Earnings (Estimated)
8/04/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SEEL
Employees
15
Year Founded
2016

Price Target and Rating

Average Stock Price Forecast
$3.33
High Stock Price Forecast
$4.00
Low Stock Price Forecast
$2.00
Forecasted Upside/Downside
+264.3%
Consensus Rating
N/A
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Net Income
$-73,530,000.00
Pretax Margin
-9,030.20%
Return on Equity
-10,287.49%

Debt

Sales & Book Value

Annual Sales
$808,000.00
Book Value
($0.10) per share

Miscellaneous

Free Float
114,015,000
Market Cap
$111.46 million
Optionable
Not Optionable
Beta
1.73

Social Links


Key Executives

  • Raj Mehra
    Chairman, President & Chief Executive Officer
  • Michael Golembiewski
    Chief Financial Officer
  • Timothy J. Whitaker
    Chief Medical Officer
  • Gopal Krishna
    Head-Manufacturing & Technical Operations
  • Karen Fusaro
    Senior Vice President & Head-Clinical Operations













SEEL Stock - Frequently Asked Questions

What is Seelos Therapeutics' stock price forecast for 2023?

0 Wall Street research analysts have issued twelve-month price targets for Seelos Therapeutics' stock. Their SEEL share price forecasts range from $2.00 to $4.00. On average, they expect the company's share price to reach $3.33 in the next year. This suggests a possible upside of 264.3% from the stock's current price.
View analysts price targets for SEEL
or view top-rated stocks among Wall Street analysts.

How have SEEL shares performed in 2023?

Seelos Therapeutics' stock was trading at $0.6790 at the start of the year. Since then, SEEL shares have increased by 34.8% and is now trading at $0.9150.
View the best growth stocks for 2023 here
.

When is Seelos Therapeutics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, August 4th 2023.
View our SEEL earnings forecast
.

How were Seelos Therapeutics' earnings last quarter?

Seelos Therapeutics, Inc. (NASDAQ:SEEL) released its quarterly earnings data on Monday, May, 15th. The company reported ($0.12) earnings per share (EPS) for the quarter. The firm had revenue of $0.81 million for the quarter.

What ETF holds Seelos Therapeutics' stock ?

AdvisorShares Psychedelics ETF holds 399,133 shares of SEEL stock, representing 5.54% of its portfolio.

What other stocks do shareholders of Seelos Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Seelos Therapeutics investors own include VBI Vaccines (VBIV), Sorrento Therapeutics (SRNE), Tonix Pharmaceuticals (TNXP), Vaxart (VXRT), Biocept (BIOC), Onconova Therapeutics (ONTX), Co-Diagnostics (CODX), Heat Biologics (HTBX), iBio (IBIO) and OPKO Health (OPK).

What is Seelos Therapeutics' stock symbol?

Seelos Therapeutics trades on the NASDAQ under the ticker symbol "SEEL."

Who are Seelos Therapeutics' major shareholders?

Seelos Therapeutics' stock is owned by many different institutional and retail investors. Top institutional investors include Gendell Jeffrey L (4.16%), BlackRock Inc. (1.36%), Mirae Asset Global Investments Co. Ltd. (1.18%), Geode Capital Management LLC (0.93%), Uniplan Investment Counsel Inc. (0.93%) and Wealth Effects LLC (0.78%). Insiders that own company stock include Daniel J O'connor and Raj Mehra.
View institutional ownership trends
.

How do I buy shares of Seelos Therapeutics?

Shares of SEEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Seelos Therapeutics' stock price today?

One share of SEEL stock can currently be purchased for approximately $0.92.

How much money does Seelos Therapeutics make?

Seelos Therapeutics (NASDAQ:SEEL) has a market capitalization of $111.46 million and generates $808,000.00 in revenue each year.

How can I contact Seelos Therapeutics?

Seelos Therapeutics' mailing address is 300 PARK AVENUE 12TH FLOOR, NEW YORK NY, 10022. The official website for the company is www.seelostherapeutics.com. The company can be reached via phone at (646) 293-2100, via email at anthony.marciano@seelostx.com, or via fax at 858-436-8155.

This page (NASDAQ:SEEL) was last updated on 6/10/2023 by MarketBeat.com Staff

My Account -